Salvage therapy for hepatocellular carcinoma with thalidomide

AIM: To evaluate the clinical benefit of thalidomide in patients with advanced hepatocellular carcinoma (hepatoma). METHODS: From March 2000 to July 2002, patients who had advanced hepatocellular carcinoma and failed to or were unsuited for aggressive treatment, were enrolled and took thalidomide 15...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Wang, Tsang-En, Kao, Chin-Roa, Lin, Shee-Chan, Chang, Wen-Hsiung, Chu, Cheng-Hsin, Lin, Johson, Hsieh, Ruey-Kuen
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2004
Matèries:
Liver Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716902/
https://ncbi.nlm.nih.gov/pubmed/14991931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i5.649
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars